Radiant Biomed Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.70 M
as on 17-07-2024
- Revenue -14.09%
(FY 2023)
- Profit -3.30%
(FY 2023)
- Ebitda 97.97%
(FY 2023)
- Net Worth 23.99%
(FY 2023)
- Total Assets -3.57%
(FY 2023)
About Radiant Biomed
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.70 M.
Rupinder Chhabra and Kanchan Chhabra serve as directors at the Company.
- CIN/LLPIN
U52100DL2014PTC263824
- Company No.
263824
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Radiant Biomed Private Limited offer?
Radiant Biomed Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Biochemistry Analyzer, IVDs & Analyzers, Hematology Analyzers, Cell Counter, Diatron Hematology Analyzers, Chemistry Analyzers.
Who are the key members and board of directors at Radiant Biomed?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupinder Chhabra  | Director | 22-Jan-2014 | Current |
| Kanchan Chhabra | Director | 22-Jan-2014 | Current |
Financial Performance of Radiant Biomed.
Radiant Biomed Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.09% decrease. The company also saw a slight decrease in profitability, with a 3.3% decrease in profit. The company's net worth Soared by an impressive increase of 23.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Radiant Biomed?
In 2022, Radiant Biomed had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Oct 2021 | ₹1.70 M | Open |
How Many Employees Work at Radiant Biomed?
Unlock and access historical data on people associated with Radiant Biomed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Radiant Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radiant Biomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
